Company ImpediMed Limited

Equities

IPD

AU000000IPD8

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:13 2024-06-06 am EDT 5-day change 1st Jan Change
0.071 AUD -4.05% Intraday chart for ImpediMed Limited -6.58% -51.03%

Business Summary

ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.

Number of employees: 76

Sales per Business

AUD in Million2022Weight2023Weight Delta
SOZO Digital Health Platform
93.1 %
10 93.5 % 11 93.1 % +6.88%
Legacy
6.0 %
1 5.8 % 1 6.0 % +12.09%
Other
0.8 %
0 0.7 % 0 0.8 % +33.80%

Sales per region

AUD in Million2022Weight2023Weight Delta
North America
72.8 %
6 57.8 % 8 72.8 % +35.29%
Unallocated
18.0 %
3 31.6 % 2 18.0 % -38.90%
Australia/Rest of World
9.2 %
1 10.6 % 1 9.2 % -6.93%

Managers

Managers TitleAgeSince
Chief Executive Officer - Jan. 07
Director of Finance/CFO - 23-09-27
Chief Tech/Sci/R&D Officer - 23-09-25
Chief Tech/Sci/R&D Officer - 07-09-30
Investor Relations Contact - 19-12-31
Sales & Marketing - -
Sales & Marketing - 19-02-28
Corporate Officer/Principal - 18-07-01
Human Resources Officer - 16-06-30
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - Jan. 07
Director of Finance/CFO - 23-09-27
Chairman - 23-09-27
Director/Board Member - 23-09-27
Director/Board Member - 23-09-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,023,307,922 1,733,929,657 ( 85.70 %) 0 85.70 %

Shareholders

NameEquities%Valuation
Paradice Investment Management Pty Ltd.
8.610 %
174,188,828 8.610 % 10 M $
Australian Ethical Investments Ltd. (Investment Management)
5.699 %
115,304,879 5.699 % 6 M $
Acadia Park Pty Ltd.
4.979 %
100,737,200 4.979 % 5 M $
MBA Investments Pty Ltd.
1.112 %
22,490,990 1.112 % 1 M $
21,263,705 1.051 % 1 M $
Greg Brown
1.043 %
21,100,000 1.043 % 1 M $
Sunlora Pty Ltd.
0.9392 %
19,000,000 0.9392 % 1 M $
Apex Investment Management Pty L
0.8636 %
17,471,778 0.8636 % 953 085 $
Pakasoluto Pty Ltd.
0.7914 %
16,011,422 0.7914 % 873 423 $
16,000,000 0.7909 % 872 800 $

Company contact information

ImpediMed Ltd.

50 Parker Court Unit 1

4008, Pinkenba

+

http://www.impedimed.com
address ImpediMed Limited(IPD)
  1. Stock Market
  2. Equities
  3. IPD Stock
  4. Company ImpediMed Limited